By leveraging berberine's documented ability to influence cellular energy regulation and glucose metabolism, this botanical product is positioned as an accessible, scientifically backed holistic alternative to naturally manage blood sugar levels and support sustainable wellness without relying solely on synthetic pharmaceuticals In December 2025, Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the results of two Phase III clinical studies of Mazdutide, the world's first approved glucagon (GCG)/glucagon-like peptide-1 (GLP-1) dual receptor agonist, in Chinese adults with type 2 diabetes (T2D) (DREAMS-1, DREAMS-2) have been published back-to-back in Nature as Accelerated Article Previews (AAP)
Enter: GLP-1s
Rifaximin versus nonabsorbable disaccharides for the treatment of hepatic encephalopathy: a meta-analysis
Statements Author contributions Select the topic, YH and XY
Figure 3 Perspective: Bariatric Surgery and Autophagy Induction Bariatric surgery, including Roux-en-Y (RYGB), gastric banding, sleeve gastrectomy (SG), and biliopancreatic diversion (BPD), has been a beneficial intervention in the treatment of obesity for reduction in body weight and is associated with the amelioration of liver steatosis and metabolic defects
Clinical recommendations based upon the patient's renal function include [see Dosage and Administration (2.2), Clinical Pharmacology (12.3)]: Before initiating JANUMET XR, obtain an estimated glomerular filtration rate (eGFR)
